PGEN · Healthcare · $3.1B
Pre-market $8.70+1.64%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“PAPZIMEOS 매출이 Q4 340만 달러 → Q1 2,160만 달러로 한 분기 만에 6배 이상 뛰었어요 — 출시 9개월 만에 처음으로 의미”
In the company's words · 2026 1분기 earnings call